The Business Magazine - South West & West Midlands’ Post

🌬️ Innovating Colorectal Cancer Screening: Breathomics 🌬️   Early detection of colorectal cancer is crucial for improving outcomes and reducing mortality. However, current screening methods still face challenges, including patient discomfort and low uptake.   ✨ Breathomics, the study of breath composition and analysis, is paving the way for non-invasive cancer detection and monitoring.   The ONCOSCREEN project is exploring the use of Artificial Intelligence to analyze Breathomics data, making screening more effective and accessible for all. 💙   Read the scientific publication authored by Ioannis K. Gallos, Dimitrios Tryfonopoulos, Gidi Shani, Angelos Amditis, Hossam Haick and Dimitra D. Dionysiou👇 https://shorturl.at/5Lu8y   #Innovation #Breathomics #ColorectalCancer #EarlyDetection #ArtificialIntelligence #Healthcare #ONCOSCREEN #EuropacolonPortugal #Screening

🌬️ Innovating Colorectal Cancer Screening: Breathomics 🌬️   Early detection of colorectal cancer is crucial for improving outcomes and reducing mortality. However, current screening methods still face challenges, including patient discomfort and low uptake.   ✨ Breathomics, the study of breath composition and analysis, is paving the way for non-invasive cancer detection and monitoring.   The ONCOSCREEN project is exploring the use of Artificial Intelligence to analyze Breathomics data, making screening more effective and accessible for all. 💙   Read the scientific publication authored by Ioannis K. Gallos, Dimitrios Tryfonopoulos, Gidi Shani, Angelos Amditis, Hossam Haick and Dimitra D. Dionysiou👇 https://shorturl.at/5Lu8y   #Innovation #Breathomics #ColorectalCancer #EarlyDetection #ArtificialIntelligence #Healthcare #ONCOSCREEN #EuropacolonPortugal #Screening

🌬️ Innovating Colorectal Cancer Screening: Breathomics 🌬️ Early detection of colorectal cancer is crucial for improving outcomes and reducing mortality. However, current screening methods still face challenges, including patient discomfort and low uptake. ✨ Breathomics, the study of breath composition and analysis, is paving the way for non-invasive cancer detection and monitoring. The ONCOSCREEN project is exploring the use of Artificial Intelligence to analyze Breathomics data, making screening more effective and accessible for all. 💙 Read the scientific publication authored by Ioannis K. Gallos, Dimitrios Tryfonopoulos, Gidi Shani, Angelos Amditis, Hossam Haick and Dimitra D. Dionysiou👇 https://shorturl.at/5Lu8y #Innovation #Breathomics #ColorectalCancer #EarlyDetection #ArtificialIntelligence #Healthcare #ONCOSCREEN #EuropacolonPortugal #Screening

Heat shock protein 70 (Hsp70) is frequently overexpressed in many different tumor types. In this paper, the authors aimed to describe Hsp70-based selection system which appears superior to an EpCAM-37 based approach in the isolation of CTCs from patients with metastatic cancer. . 📝 Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers — Xanthopoulos, et al. Full text is available 👇 https://lnkd.in/d6nBcdZq #medicine #health #research #science 

Researchers Develop New Non-invasive Test for Early Detection of Cervical Cancer Researchers have developed a new non-invasive test technology that could help in early detection of cervical cancer, giving hope for effortless screening and prevention in the future. As reported by MPO, the new test that can detect crucial cervical cancer biomarkers in urine was developed by researchers from Waseda University in Japan in collaboration with a German scientist, Martin Müller, from the DKFZ German Cancer Research Center. Read more:https://lnkd.in/gzYYWrxQ #HealthcareNews #healthcareinnovation #HealthcareTechnology #Ai #medicaldevice #CervicalCancer #ELISAtest #CervicalCancerScreening #nextdigitalhealth #vineetagrawal #Wi4

𝐖𝐡𝐚𝐭𝐬𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠: 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬! The future of cancer detection is here! 🩺 Researchers at the University of Edinburgh have introduced a groundbreaking AI-laser method, achieving a stunning 98% accuracy in detecting stage 1A breast cancer. 🚀 By combining laser analysis (Raman spectroscopy) with artificial intelligence, this non-invasive blood test detects subtle chemical changes in plasma, which were previously undetectable using traditional methods. 𝐖𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬: Detects breast cancer at the earliest stage, enabling life-saving interventions. Non-invasive and highly precise, revolutionizing early diagnosis. This innovation is a significant leap forward in cancer care, offering a quicker, safer, and more reliable approach to detection. At 𝐒𝐡𝐚𝐫𝐝𝐚 𝐂𝐚𝐫𝐞 - 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐢𝐭𝐲, we are committed to adopting such transformative advancements for a healthier future. 💡✨ #WhatsTrending #BreastCancerDiagnosis #AIinHealthcare #HealthInnovation #ShardaCareHealthcity #ShardaCare #FutureOfMedicine #AccessibleHealthcare #GameChanger

#CancerMedicine | 𝗡𝗼𝘃𝗲𝗹 𝗕𝗹𝗼𝗼𝗱 𝗧𝗲𝘀𝘁 𝗛𝗲𝗹𝗽𝘀 𝗜𝗺𝗽𝗿𝗼𝘃𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 | Researchers at the University of Zurich and the University Hospital Zurich, led by Professor Panagiotis Balermpas, have developed an innovative blood test to enhance cancer treatments. This novel liquid biopsy method analyzes DNA fragments in the bloodstream to determine tumor activity, distinguishing between less and more aggressive metastatic cancer. The research team tested their groundbreaking method on patients undergoing radiotherapy, including several HPV-positive individuals. They discovered that higher concentrations of HPV DNA in the blood might signal early cancer recurrence, especially for head and neck cancers. This discovery is crucial as it allows for a personalized assessment of therapy benefits and risks while enabling regular monitoring of treatment success, leading to more tailored and effective cancer treatments. 👉 Learn more >> https://lnkd.in/gtzQNx-G 👉 Original publication >> https://lnkd.in/gMPdP7a3 Photo: iStock/mrfiza 🇨🇭 Follow #ScienceSwitzerland for the latest news and emerging trends on Swiss science, technology, education, and innovation >> www.swissinnovation.org Follow us >> Science-Switzerland #Science | #Education | #Research | #Innovation

13.5% of all cancers in India are Breast Cancer and 10.6% of all cancer-deaths are due to Breast Cancer, is this TARGETED NANOBOT TECHNOLOGY, using Single-Walled Carbon Nanotube (SWCNT) as potent therapeutic nanobomb agents for killing Breast Cancer, workable? Do you know that an Indian scientist Dr. Balaji Panchapakesan has developed it? Read more - https://bit.ly/3WXUj8q Follow Careerbuilder for Healthcare Professionals - India & Gulf Countries #healthtech #healthcare #india #doctors #hospitals #cancer #cancercare #cancertherapy #breastcancer #targetedtherapy #nanotechnology

#KeepItSimple, #Science Beyond the Barrier: Innovations in Cancer Treatment and the Blood-Brain Challenge 🛡 The blood-brain barrier (BBB) plays a crucial role in protecting the brain but also creates significant challenges in treating brain cancers. This carousel explores: 🔑 What the BBB is and how it works 💡 Why the BBB complicates cancer therapies 🧬 Innovative solutions like nanotechnology, focused ultrasound, and immunotherapy Curious how researchers are working to bypass this barrier and improve brain cancer treatment? 👉 Swipe through the carousel to learn more! #KeepItSimpleScience #CancerResearch #BloodBrainBarrier #CancerTreatment #MedicalInnovation #HealthcareScience

💡 𝗟𝟭𝗖𝗔𝗠 𝗲𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻: 𝗮 𝗻𝗲𝘄 𝘁𝗮𝗿𝗴𝗲𝘁 𝗳𝗼𝗿 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀? According to the seed and soil theory, also known as the Paget’s hypothesis, the 𝘁𝘂𝗺𝗼𝗿 𝗺𝗶𝗰𝗿𝗼𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁 (𝗧𝗠𝗘) plays a key role in promoting the onset and progression of cancer. There are numerous molecules that confer 𝗽𝗿𝗼𝘁𝘂𝗺𝗼𝗿𝗶𝗴𝗲𝗻𝗶𝗰 𝗽𝗿𝗼𝗽𝗲𝗿𝘁𝗶𝗲𝘀 to the cells of the TME. The aim of this study was to analyze in a series of colorectal cancers the expression of the 𝗟𝟭 𝗰𝗲𝗹𝗹 𝗮𝗱𝗵𝗲𝘀𝗶𝗼𝗻 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲 (𝗟𝟭𝗖𝗔𝗠) in the cells of the TME, in order to better clarify the role of these cells in 𝗰𝗼𝗹𝗼𝗿𝗲𝗰𝘁𝗮𝗹 𝗰𝗮𝗻𝗰𝗲𝗿 (𝗖𝗥𝗖) onset and progression. The results obtained from this work suggest that the study of L1CAM expression in the peritumoral infiltrating cells in CRC patients could represent a valid tool able to stratify these patients regarding the possible occurrence of #metastasis and recurrence. 🔗 Access the full study: https://lnkd.in/dC5Zhx-Z EIC Prof. Antonio Giordano - Sbarro Health Research Organization & 𝗖𝗮𝗿𝗺𝗶𝗻𝗲 𝗣𝗶𝗻𝘁𝗼 - AUSL Reggio Emilia Executive Ed. Prof. Francesca Pentimalli - Università LUM Edra S.p.A. #oncology #oncologyresearch #colorectalcancer #cancer #cancercare #research #oncologists #patientcare by Drs. 𝗙𝗹𝗮𝘃𝗶𝗮𝗻𝗮 𝗖𝗮𝘂, 𝗖𝗹𝗮𝗿𝗮 𝗚𝗲𝗿𝗼𝘀𝗮, Pina Ziranu, Andrea Pretta, 𝗠𝗼𝗻𝗶𝗰𝗮 𝗣𝗶𝗿𝗮𝘀, Matteo Fraschini, 𝗣𝗲𝘁𝗲𝗿 𝗩𝗮𝗻 𝗘𝘆𝗸𝗲𝗻, 𝗚𝗶𝗼𝗿𝗴𝗶𝗼 𝗟𝗮 𝗡𝗮𝘀𝗮, 𝗠𝗮𝘀𝘀𝗶𝗺𝗼 𝗖𝗮𝘀𝘁𝗮𝗴𝗻𝗼𝗹𝗮, Ferdinando Coghe, Germano Orrù, Luigi Zorcolo, Andrei Turtoi, 𝗔𝗻𝘁𝗼𝗻𝗲𝗹𝗹𝗮 𝗕𝗮𝗹𝗲𝘀𝘁𝗿𝗶𝗲𝗿𝗶, Luca Saba, Mario Scartozzi, 𝗚𝗮𝘃𝗶𝗻𝗼 𝗙𝗮𝗮